Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,807 | 538 | 82.3% |
| Travel and Lodging | $1,243 | 8 | 15.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $225.00 | 1 | 2.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,709 | 348 | $0 (2024) |
| Covidien LP | $551.36 | 6 | $0 (2017) |
| Boston Scientific Corporation | $521.13 | 4 | $0 (2018) |
| Takeda Pharmaceuticals U.S.A., Inc. | $354.95 | 20 | $0 (2024) |
| Nestle HealthCare Nutrition Inc. | $335.38 | 36 | $0 (2022) |
| Janssen Biotech, Inc. | $323.37 | 29 | $0 (2024) |
| Apollo Endosurgery US Inc | $268.61 | 1 | $0 (2018) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $257.70 | 13 | $0 (2024) |
| Shire North American Group Inc | $225.00 | 1 | $0 (2018) |
| Synergy Pharmaceuticals Inc | $153.30 | 10 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,165 | 81 | ABBVIE INC. ($765.66) |
| 2023 | $833.40 | 56 | ABBVIE INC. ($564.87) |
| 2022 | $1,660 | 118 | ABBVIE INC. ($879.53) |
| 2021 | $1,180 | 101 | AbbVie Inc. ($655.15) |
| 2020 | $357.66 | 31 | AbbVie Inc. ($224.69) |
| 2019 | $406.43 | 45 | AbbVie, Inc. ($263.33) |
| 2018 | $1,485 | 56 | Boston Scientific Corporation ($521.13) |
| 2017 | $1,188 | 59 | Covidien LP ($551.36) |
All Payment Transactions
547 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $0.23 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $17.26 | General |
| Category: GI | ||||||
| 11/21/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $3.47 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/14/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.03 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/13/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: Immunology | ||||||
| 11/12/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/06/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $0.22 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $8.88 | General |
| Category: VIROLOGY | ||||||
| 10/31/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/24/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $9.91 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $0.72 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/09/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $0.31 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: IMMUNOLOGY | ||||||
| 09/30/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/24/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: IMMUNOLOGY | ||||||
| 09/17/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $26.42 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/11/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $33.43 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 629 | 698 | $449,259 | $76,412 |
| 2022 | 18 | 748 | 817 | $509,530 | $78,595 |
| 2021 | 20 | 1,054 | 1,166 | $636,719 | $114,843 |
| 2020 | 17 | 963 | 1,105 | $509,029 | $98,555 |
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 163 | 164 | $192,536 | $31,023 | 16.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 61 | 61 | $19,215 | $6,984 | 36.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 57 | 65 | $13,390 | $5,753 | 43.0% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 48 | 58 | $27,898 | $5,675 | 20.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 100 | 103 | $67,671 | $5,379 | 7.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 42 | 86 | $15,996 | $5,182 | 32.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 45 | 46 | $16,146 | $4,448 | 27.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 27 | 27 | $22,356 | $4,106 | 18.4% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 21 | 22 | $17,909 | $3,511 | 19.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 38 | 38 | $37,582 | $1,680 | 4.5% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 16 | 17 | $9,452 | $1,370 | 14.5% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 11 | 11 | $9,108 | $1,300 | 14.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 151 | 152 | $178,448 | $26,260 | 14.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 64 | 86 | $17,716 | $6,797 | 38.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 118 | 120 | $78,840 | $6,129 | 7.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 62 | 62 | $19,530 | $5,871 | 30.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 54 | 55 | $15,905 | $5,444 | 34.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 57 | 87 | $13,167 | $4,602 | 35.0% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2022 | 38 | 47 | $22,607 | $4,312 | 19.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 22 | 22 | $17,909 | $3,266 | 18.2% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 14 | 14 | $11,592 | $2,403 | 20.7% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 20 | 21 | $16,836 | $2,380 | 14.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 38 | 39 | $38,571 | $2,111 | 5.5% |
| 43251 | Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare | Facility | 2022 | 17 | 17 | $11,391 | $1,905 | 16.7% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 23 | 24 | $13,129 | $1,685 | 12.8% |
About Dr. Sunil Ramrakhiani, MD
Dr. Sunil Ramrakhiani, MD is a Gastroenterology healthcare provider based in Fort Wayne, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1407805849.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sunil Ramrakhiani, MD has received a total of $8,275 in payments from pharmaceutical and medical device companies, with $1,165 received in 2024. These payments were reported across 547 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($6,807).
As a Medicare-enrolled provider, Ramrakhiani has provided services to 3,394 Medicare beneficiaries, totaling 3,786 services with total Medicare billing of $368,404. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Fort Wayne, IN
- Active Since 05/10/2006
- Last Updated 09/29/2020
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1407805849
Products in Payments
- LINZESS (Drug) $1,024
- RINVOQ (Biological) $564.89
- Barrx (Device) $551.36
- GENERAL POLYPECTOMY (Device) $521.13
- MAVYRET (Drug) $440.76
- STELARA (Biological) $398.83
- SKYRIZI (Biological) $364.82
- ZENPEP (Drug) $335.38
- HUMIRA (Biological) $332.62
- Overstitch (Device) $268.61
- Creon (Drug) $251.52
- ENTYVIO (Biological) $220.15
- XIFAXAN (Drug) $194.14
- CREON (Drug) $180.08
- VIBERZI (Drug) $174.02
- Humira (Biological) $164.38
- Trulance (Drug) $153.30
- GI GENIUS (Device) $138.16
- DIFICID (Drug) $134.25
- OMVOH (Drug) $112.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Fort Wayne
Dr. Efesomwan Aisien, M.d, M.D
Gastroenterology — Payments: $89,557
Dr. Abdo Saad, Md, MD
Gastroenterology — Payments: $59,492
Melissa Garrett, Md, MD
Gastroenterology — Payments: $59,090
Dr. Mariajose Rojas De Leon, Md, MD
Gastroenterology — Payments: $39,782
Dr. Kirsten Weiser, M.d, M.D
Gastroenterology — Payments: $20,935
Dr. David Gutman, Md, Facg, MD, FACG
Gastroenterology — Payments: $13,732